(Q44863033)

6 December 2017

1 reference

title

First International Symposium on Influenza and Other Respiratory Viruses: summary and overview: Kapalua, Maui, Hawaii, December 4-6, 1998. (English)

1 reference

6 December 2017

L Kaiser

1

1 reference

6 December 2017

R B Couch

2

1 reference

6 December 2017

G J Galasso

3

1 reference

6 December 2017

W P Glezen

4

1 reference

6 December 2017

R G Webster

5

1 reference

6 December 2017

P F Wright

6

1 reference

6 December 2017

F G Hayden

7

1 reference

6 December 2017

language of work or name

1 reference

1 July 1999

1 reference

6 December 2017

1 reference

6 December 2017

42

1 reference

6 December 2017

3

1 reference

6 December 2017

149-175

1 reference

Cytokine profiles of bronchoalveolar lavage cells from mice with influenza pneumonia: consequences of CD4+ and CD8+ T cell depletion

6 December 2017

1 reference

12 December 2020

Computed tomographic study of the common cold

1 reference

12 December 2020

Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction

1 reference

12 December 2020

Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection

1 reference

12 December 2020

Detection of rhinovirus in sinus brushings of patients with acute community-acquired sinusitis by reverse transcription-PCR.

1 reference

12 December 2020

Duration of antiviral prophylaxis during nursing home outbreaks of influenza A: a comparison of 2 protocols

1 reference

12 December 2020

Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line

1 reference

12 December 2020

An evaluation of clinical indicators for severe paediatric illness

1 reference

12 December 2020

Anti-influenza virus activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and in human respiratory epithelium

1 reference

12 December 2020

Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus

1 reference

12 December 2020

Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children

1 reference

12 December 2020

Effects of upper respiratory tract infections in patients with cystic fibrosis

1 reference

12 December 2020

Respiratory viruses and exacerbations of asthma in adults

1 reference

12 December 2020

Community study of role of viral infections in exacerbations of asthma in 9-11 year old children

1 reference

12 December 2020

Safety and efficacy of long-term use of rimantadine for prophylaxis of type A influenza in nursing homes

1 reference

12 December 2020

A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion

1 reference

12 December 2020

The effects of malnutrition on child mortality in developing countries

1 reference

12 December 2020

Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects

1 reference

12 December 2020

Respiratory syncytial virus infection enhances neutrophil and eosinophil adhesion to cultured respiratory epithelial cells. Roles of CD18 and intercellular adhesion molecule-1.

1 reference

12 December 2020

Recovery of a fully viable chimeric human parainfluenza virus (PIV) type 3 in which the hemagglutinin-neuraminidase and fusion glycoproteins have been replaced by those of PIV type 1.

1 reference

12 December 2020

Viral etiology and epidemiology of acute respiratory infections in children in Nairobi, Kenya

1 reference

12 December 2020

Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum

1 reference

12 December 2020

Virus-induced airway hyperresponsiveness and asthma

1 reference

12 December 2020

Seasonal trends of viral respiratory tract infections in the tropics

1 reference

12 December 2020

Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group

1 reference

12 December 2020

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

1 reference

12 December 2020

Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects

1 reference

12 December 2020

Polymerase chain reaction-based detection of rhinovirus, respiratory syncytial virus, and coronavirus in otitis media with effusion

1 reference

12 December 2020

Cellular immunity is activated and a TH-2 response is associated with early wheezing in infants after bronchiolitis

1 reference

12 December 2020

IL-8 release from human neutrophils by the respiratory syncytial virus is independent of viral replication.

1 reference

12 December 2020

Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza

1 reference

12 December 2020

Viral lower respiratory tract infections in Filipino children

1 reference

12 December 2020

Giant cell pneumonia due to respiratory syncytial virus. Occurrence in severe combined immunodeficiency syndrome

1 reference

12 December 2020

A new look at T cells

1 reference

12 December 2020

Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivity.

1 reference

12 December 2020

Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.

1 reference

12 December 2020

A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41.

1 reference

12 December 2020

Bronchial hyperresponsiveness and cytokines in virus-induced asthma exacerbations

1 reference

12 December 2020

Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus.

1 reference

12 December 2020

Immunological responses to respiratory syncytial virus infection in infancy

1 reference

12 December 2020

Bronchiolitis in tropical south India

1 reference

12 December 2020

Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group

1 reference

12 December 2020

The clinical spectrum of respiratory syncytial virus disease in The Gambia

1 reference

12 December 2020

A single nucleotide substitution in the transcription start signal of the M2 gene of respiratory syncytial virus vaccine candidate cpts248/404 is the major determinant of the temperature-sensitive and attenuation phenotypes

1 reference

12 December 2020

Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: prospective cohort study

1 reference

12 December 2020

Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin

1 reference

12 December 2020

Clearance of an influenza A virus by CD4+ T cells is inefficient in the absence of B cells

1 reference

12 December 2020

Detection of rhinovirus RNA in lower airway cells during experimentally induced infection

1 reference

12 December 2020

Protection of infants from infection with influenza A virus by transplacentally acquired antibody

1 reference

12 December 2020

The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis

1 reference

12 December 2020

Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children

1 reference

12 December 2020

New approaches to influenza chemotherapy. Neuraminidase inhibitors

1 reference

12 December 2020

Induction of Partial Immunity to Influenza by a Neuraminidase-specific Vaccine

1 reference

12 December 2020

Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden

1 reference

12 December 2020

Respiratory syncytial virus and influenza A infections in the hospitalized elderly

1 reference

12 December 2020

Rapid simultaneous diagnosis of infections with respiratory syncytial viruses A and B, influenza viruses A and B, and human parainfluenza virus types 1, 2, and 3 by multiplex quantitative reverse transcription-polymerase chain reaction-enzyme hybrid

1 reference

12 December 2020

Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children

1 reference

12 December 2020

Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp45) human parainfluenza virus 3 candidate vaccine.

1 reference

12 December 2020

Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo

1 reference

12 December 2020

Acute Respiratory Viral Infections in Ambulatory Children of Urban Northeast Brazil

1 reference

12 December 2020

Different patterns of cytokine induction in cultures of respiratory syncytial (RS) virus-specific human TH cell lines following stimulation with RS virus and RS virus proteins

1 reference

12 December 2020

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

12 December 2020

Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden

1 reference

12 December 2020

Cytokines and impaired CD8+ CTL activity among elderly persons and the enhancing effect of IL-12

1 reference

12 December 2020

Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells

1 reference

12 December 2020

Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group

1 reference

12 December 2020

Rhinovirus infection preferentially increases lower airway responsiveness in allergic subjects

1 reference

12 December 2020

Quantitation of human influenza virus-specific cytotoxic T lymphocytes: correlation of cytotoxicity and increased numbers of IFN-gamma producing CD8+ T cells

1 reference

12 December 2020

Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults.

1 reference

12 December 2020

The epidemiology of acute respiratory tract infection in young children: comparison of findings from several developing countries. Coordinated Data Group of BOSTID Researchers.

1 reference

12 December 2020

Etiology of acute respiratory tract infections among children in a combined community and hospital study in Rio de Janeiro

1 reference

12 December 2020

Inhibition of virus release by antibodies to surface antigens of influenza viruses

1 reference

12 December 2020

Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus-induced asthma

1 reference

12 December 2020

Prevention and control of type A influenza infections in nursing homes. Benefits and costs of four approaches using vaccination and amantadine

1 reference

12 December 2020

Initial genetic characterization of the 1918 "Spanish" influenza virus

1 reference

12 December 2020

Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion

1 reference

12 December 2020

Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats

1 reference

12 December 2020

Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge

1 reference

12 December 2020

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

1 reference

12 December 2020

Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells

1 reference

12 December 2020

10.1016/S0166-3542(99)00034-0

Identifiers

DOI

1 reference

6 December 2017

0 references

1 reference